Test new drug-eluting stent with less blood thinner
Part of Heart & circulation clinical trials.
This study compares a new type of “drug-eluting” stent (a tiny scaffold that slowly releases medicine) and a single blood-thinner plan versus the usual two-drug blood thinner plan after stent placement in the left main coronary artery. It aims to see if the simpler plan can work while keeping the stent safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re 18 or older.
- You have recent or ongoing heart chest pain from blocked heart arteries (unstable angina or non–ST-elevation acute coronary syndrome).
- You’re having (or just had) a successful stent procedure in the “left main” artery that is not covered by a previous stent, using this specific ultrathin drug-eluting stent.
- You can read and sign the consent form before the procedure.
- You must be able and willing to follow a prescribed blood-thinner plan for at least 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if using a drug-coated balloon (a balloon that slowly releases medicine to keep the artery open) improves results after placing a standard stent in the left main coronary artery (the main pipe supplying blood to the heart) and its first two branches. It may help people with complex narrowing in that area who have not had prior stenting there.
This trial studies whether a specific stent (with no polymer coating) plus a single blood thinner plan with aspirin and another P2Y12 medicine is as safe and effective as the standard two-medicine plan after a STEMI heart attack. It may help people avoid longer exposure to stronger blood-thinning if the new approach works as well.
This trial tests if a shorter, lower dose of two blood thinners is safe and effective for patients with a recent heart attack or unstable angina who are at high risk for bleeding. It uses a special stent that might allow for less medication.
This trial tests an algorithm (computer-guided plan) to choose the best “dual antiplatelet therapy” (two blood-thinning medicines) after a coronary stent. It aims to improve outcomes after the procedure while reducing avoidable problems from the medicines.
This study looks at whether choosing blood thinners based on each person's needs works better than a standard approach after getting a heart stent. It aims to reduce risks like blood clots or bleeding.
This trial compares two different ways of placing stents in the main heart artery on the left side and its first branch. It aims to see which method works better for people with blockages at this critical junction.
Hear when a new Left Main Coronary Artery Stenosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.